Nafamostat Efficacy in Phase 3 Registrational CRRT Study

计划入组 70 人 · 首次发布于 2023 年 11 月 29 日

Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease

计划入组 1,676 人 · 首次发布于 2014 年 10 月 15 日

Test and Evaluation of Non-Invasive Neuro-Assessment Devices (NINAD): NeuroKinetics, Inc, iPAS

计划入组 150 人 · 首次发布于 2017 年 5 月 24 日

NYAD-201

NYAD-13

NYAD-202

Talphera's Niyad Receives FDA Agreement for Enrollment Acceleration in NEPHRO CRRT Trial

CorMedix Makes $5 Million Strategic Investment in Talphera's Phase 3 Anticoagulant Program

Talphera's nafamostat gains KDIGO endorsement as NEPHRO CRRT trial nears completion